Join the Cough and Nasal Congestion group to help and get support from people like you.
Cough and Nasal Congestion News
Related terms: Cough and Blocked Nose
AI Outperforms Urgent Care Docs, Study Says
TUESDAY, April 8, 2025 – Cough? Sore throat? UTI? Eye infection? Artificial intelligence (AI) might one day be seeing you for these sorts of conditions, a new study says. AI programs appear to...
1 in 6 U.S. Adults With Asthma Can't Afford Meds
TUESDAY, Dec. 10, 2024 – Over 3 million Americans with asthma can't afford to take their medications as prescribed, a new poll estimates. In total, about 1 in 6 folks with asthma are struggling to...
Wildfire Smoke Is Choking America's Cities -- Is Yours on the List?
TUESDAY, Dec. 10, 2024 – Heavy smoke from wildfires more frequently chokes the skies over the Western United States, but cities farther to the east are no longer being spared, new research shows....
Researchers Compare Race-Based, Race-Neutral Lung Function Equations
TUESDAY, May 21, 2024 – The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in terms of disease...
Your Allergy Meds Come With Hazards: Be Aware
SATURDAY, May 18, 2024 – People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes,...
FDA Panel Says Common OTC Decongestant, Phenylephrine, Is Useless
TUESDAY, Sept. 12, 2023 – For decades, sick people have been taking essentially worthless over-the-counter cold remedies to clear their stuffy noses, a key advisory panel for the U.S. Food and Drug...
Vernalis and Tris Pharma Receive FDA Approval for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex)
May 1, 2015 – Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and...
FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution
MADISON, Miss.--(BUSINESS WIRE)--Jun 13, 2011 - Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for Rezira (hydrocodone...
FDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution
MADISON, Miss.--(BUSINESS WIRE)--Jun 13, 2011 - Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for Zutripro (hydrocodone...
FDA Medwatch Alert: Cough and Cold Medications in Children Less Than Two Years of Age - Jan 17, 2008
[Posted 01/17/2008] FDA informed consumers and healthcare professionals that the Agency has completed its review of information regarding the safety of over-the-counter (OTC) cough and cold medicines...
FDA Medwatch Alert: Nonprescription Cough and Cold Medicine Use in Children
[Posted August 15, 2007] FDA announced that on October 18 - 19, 2007, the Nonprescription Drugs Advisory Committee will discuss the safety and effectiveness of cough and cold drug product use in...
FDA Medwatch Alert: Cough and Cold Medications in Children Less Than Two Years of Age - Jan 12, 2007
[Posted 01/12/2007] The Centers for Disease Control and Prevention (CDC) issued a Morbidity and Mortality Weekly Report (MMWR) article describing three deaths in U.S. infants aged less than 12 months...
FDA Medwatch Alert: WellPatch Cough & Cold Soothing Vapor Pads
[Posted 08/01/2006] The Mentholatum Company and FDA notified consumers and healthcare professionals about a nationwide recall of WellPatch Cough & Cold Soothing Vapor Pads due to potential serious...